negative side effects of glp-1 drugs can cause pancreatitis, kidney injury, bowel obstruction, ministry warns Struggling with GLP-1 therapy side

Despite the increasing insulin drug prices, with the increasing type-1 population in Europe, the market for insulin drugs is increasing, and there is no alternative

Researchers estimate that if Medicare were to lift the prohibition on coverage of GLP-1s for weight loss alone and institute broad coverage of semaglutide-based products, this could prevent nearly 39,000 cardiovascular events and the program could save over $700 million in net costs over ten years

Symptoms may include dull aching pain, throbbing, or pressure in the head

Watch: how to afford GLP-1 in 2026 A breakdown of GLP-1 pricing, insurance coverage pathways, and the new programs making these medications more affordable in 2026

K86.1 (chronic pancreatitis, coded first) E08.9 (diabetes due to underlying condition, no complications) Example E: Diabetic Foot Ulcer Type 2 diabetic on insulin